Science World Honors Kevan Shokat for High-Impact Cancer Research
Kevin Shokat, who developed a successful approach to drugging a protein produced by the KRAS gene, has received two prestigious scientific awards.
University of California San Francisco
Give to UCSF
Displaying 91 - 120 of 1062
-
-
Plant-based Foods May Reduce Prostate Cancer Progression, Study Says
-
“Smarter” Breast Cancer Screening Measures Risk Down to Your DNA
The WISDOM 2.0 study aims to transform breast cancer screening by using a personalized approach and will expand to women as young as 30.
-
If Immunity Is Innate, What Impacts Our Ability to Fight Infections?
Balyn Zaro’s lab investigates the cause and consequence of genetic diversity in the immune system, in hopes that her discoveries can lead to better treatments for all patients.
-
Breast Cancer Risk Calculator Can Assess Risk of Advanced Cancer
A new digital tool helps calculate breast cancer risk for those who may develop advanced cancer that goes undiagnosed despite regular screenings.
-
Big Little Lives
Trillions of invisible organisms make up the human microbiome. Now, medical scientists want to put these bugs to work.
-
The Radical Compassion of Awake Brain Surgery
On the operating table and inside the lab of a rising star in cancer neurosurgery.
-
Aggressive Surgery Increases Survival with Low-Grade Brain Tumors
Resecting brain tumors called gliomas as much as possible soon after diagnosis offers a distinct survival advantage when looking at the disease trajectory 10 years later, find UCSF researchers.
-
UCSF Researchers Uncover New Pathway for Molecular Cancer Drug Therapies
Researchers have discovered a cellular uptake pathway for larger molecules that delivers cell-permeable drugs efficiently.
-
Rethinking How Cancer Cells Evade Targeted Therapy
Through decades of biobanking at UCSF, researchers were able to comprehensively map intra-cellular signaling in the cells of recurrent glioblastoma, identifying novel cell-extrinsic therapeutic targets.
-
Killing Pancreatic Cancer with T Cells that Supercharge Themselves
T-cells can be directed to produce cytokine, a powerful anti-cancer component, when they encounter cancer cells. This holds tremendous promise for cancer immunotherapy.
-
International Hematologic Conference Features UCSF Health Experts
UCSF experts in multiple myeloma and other hematologic malignancies will attend the American Society of Hematology’s (ASH) 64th Annual Meeting and Exposition.
-
How AI Found the Words to Kill Cancer Cells
A new sophisticated machine learning technique using a molecular library of commands guides engineered immune cells to seek out and tirelessly kill cancer cells.
-
International Conference Features UCSF Breast Cancer Experts
UCSF breast cancer experts will present new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the largest and most prestigious breast cancer conference.
-
More than 30 Researchers Among Most Influential
38 UCSF researchers rank in the top 1 percent for impact in their fields, according to a new analysis of research citations by science and intellectual property company Clarivate.
-
UCSF Cancer Specialist Recognized with Luminary Award for Gastrointestinal Cancers
Alan P. Venook, MD, a renowned expert in colorectal and liver cancers, has been announced as one of the winners of the 2022 Luminary Awards in Gastrointestinal (GI) Cancers.
-
Myocarditis in Cancer Patients Is Driven by Specific Immune Cells
Researchers have identified specific immune cells that drive deadly heart inflammation in a small fraction of patients treated with powerful cancer immunotherapy drugs.
-
Marijuana and E-cigs Can Harm the Heart Like Traditional Cigarettes
E-cigarettes and marijuana have similar harmful effects on the heart as tobacco cigarettes, opening the door to abnormal heart rhythms, reports a team of researchers at UCSF.
-
“CAR Pooling” Screens Identify Most Effective Cancer Immunotherapy Cells
A new method of comparing massive numbers of CAR-T cells can determine which is most effective and long-lasting against cancer.
-
Can Gut Microbes Impact Chemotherapy? So Far, the Answer is ‘Yes’
Bacteria in our guts may play a significant role in the metabolism of anti-cancer drugs that are critical for treating colon cancer and other types of cancers.
-
UCSF Study Sheds Light on the Reasons Behind Sex Differences in Myocarditis
Immune checkpoint inhibitors (ICIs) used in cancer care can cause myocarditis, a potentially fatal side effect, and it appears that the adverse cardiac effects may disproportionally impact female patients.
-
Uterine Cancer Cases Are Rising. Here’s What to Know.
-
UCSF Hosts First Lady Jill Biden to Discuss Breast Cancer Research
First Lady Jill Biden, Ed.D, met with top UCSF cancer leaders during a visit Friday, October 7th, to hear about UCSF’s breast cancer research and progress on the National Cancer Moonshot.
-
Hackathon Prepares Young Researchers for the Collaborative Science of the Future
On a sunny Friday, teams of aspiring young scientists gathered in the Clinical Sciences building at Parnassus Heights to look for treasure in a trillion data points about cancer.
-
Drug Turns Cancer Gene Into ‘Eat Me’ Flag for Immune System
A new therapy pulls forward a mutated version of the KRAS protein to help the immune system recognize and destroy cancer cells.
-
UCSF Scientist Says Biden’s Cancer Moonshot Achievable
-
New Study Finds ‘Widespread Exposure’ to Cancer-Causing Chemicals During Pregnancy
-
Research Reveals Mechanisms at Work in Progression of Pancreatic Cysts to Pancreatic Cancer
UCSF-led research outlines the comprehensive immune landscape and microbiome of pancreatic cysts as they progress from benign cysts to pancreatic cancer. Their findings could reveal the mechanism of neoplastic progression and provide targets for immunotherapy to inhibit progression or treat invasive disease.
-
Pregnant Women Exposed to Cancer-Causing Chemicals in Dishware, Hair Coloring, Plastics, and Pesticides
Pregnant women in the U.S. are being exposed to chemicals like melamine, cyanuric acid, and aromatic amines that can increase the risk of cancer and harm child development, according to a study from researchers at UCSF and Johns Hopkins Bloomberg School of Public Health.
-
Giving Immunotherapy Cells Resilience to Pass the ‘Stress Test’
T cells used in immunotherapy treatments can get exhausted and shut down by fighting cancer cells and tumors. Using a CRISPR-based edit on these cells’ genomes, researchers at UCSF and Gladstone Institutes have rendered the therapeutic cells more resilient against tumors.
